Skip to main content
. 2021 Jun 14;8:693351. doi: 10.3389/fcvm.2021.693351

Table 1.

Baseline characteristics by testosterone tertiles of men undergoing carotid endarterectomy.

Overall Low Medium High
n 203 68 68 67
Testosterone nmol/mL [median (IQR)] 11.6 (8.6–13.8) 7.6 (5.7–8.6) 11.6 (10.6–12.7) 16.5 (14.9–18.9)
Age [years; mean (SD)] 68 (8.8) 69 (9.6) 69 (7.5) 68 (9.2)
Body mass index [mean (SD)] 26.6 (3.6) 27.0 (3.9) 26.8 (3.64) 25.8 (3.3)
Renal function [GFR; mean (SD)] 75 (22) 74 (26) 73 (18) 79 (20)
Total Cholesterol [mean (SD)] 4.0 (1.1) 3.7 (1.0) 4.0 (1.2) 4.4 (1.1)
Triglycerides [mean (SD)] 1.6 (0.8) 1.7 (0.9) 1.7 (0.7) 1.5 (0.8)
LDL [mean (SD)] 2.3 (0.9) 2.1 (0.8) 2.3 (0.9) 2.5 (0.9)
HDL [mean (SD)] 1.0 (0.3) 0.9 (0.3) 1.0 (0.3) 1.1 (0.3)
Current smoker = yes, n (%) 70 (35) 23 (34) 26 (38) 21 (31)
Diabetes Mellitus = yes, n (%) 37 (18) 19 (28) 13 (19) 5 (8)
Hypercholesterolemia = yes, n (%) 127 (68) 45 (73) 46 (72) 36 (60)
Hypertension = yes, n (%) 135 (69) 52 (79) 46 (69) 37 (59)
History of coronary artery disease = yes, n (%) 65 (32) 22 (32) 24 (35) 19 (28)
History of stroke = yes, n (%) 54 (27) 22 (32) 16 (24) 16 (24)
History of peripheral artery disease = yes, n (%) 44 (22) 19 (28) 15 (22) 10 (15)
Symptoms group, n (%)
   Asymptomatic 38 (19) 11 (17) 16 (24) 11 (17)
   Ocular 31 (16) 11 (17) 10 (15) 10 (15)
   Stroke 46 (23) 18 (28) 13 (19) 15 (23)
   Transient ischemic attack 84 (42) 25 (39) 29 (43) 30 (46)
Plaque phenotype, n (%)
   Atheromatous 63 (32) 23 (34) 18 (27) 22 (33)
   Fibro-atheromatous 67 (34) 22 (33) 22 (33) 23 (35)
   Fibrous 70 (35) 22 (33) 27 (40) 21 (32)
Statins or lipid lowering medication = yes, n (%) 158 (78) 54 (79) 53 (78) 51 (76)
Antiplatelet medication = yes, n (%) 186 (92) 60 (88) 63 (93) 63 (94)